Immune profiling of Alzheimer patients

Journal of Neuroimmunology

Volumn 242, Issue 1-2, 2012, Pages 52-59

  Pellicanò, Mariavaleria ^a   Larbi, Anis ^b   Goldeck, David ^a   Colonna Romano, Giuseppina ^c   Buffa, Silvio ^c   Bulati, Matteo ^c   Rubino, Graziella ^a   Iemolo, Francesco ^d   Candore, Giuseppina ^c   Caruso, Calogero ^c   Derhovanessian, Evelyna ^a   Pawelec, Graham ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b AGENCY FOR SCIENCE   (Singapore)

^c UNIVERSITY OF PALERMO   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

A 42; Alzheimer's disease; Immunosenescence; T cells

Indexed keywords

AMYLOID BETA PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE PROFILING; IMMUNOLOGICAL PROCEDURES; LYMPHOCYTE DIFFERENTIATION; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84856802632     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.11.005     Document Type: Article

References (41)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation in Alzheimer's disease. Neuroinflammation working group. Neurobiol. Aging 2000, 21:383-421.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders: DSM-III-R 1987, American Psychiatric Association, Washington (DC). 3rd revised ed.
3. Britschgi M., Wyss-Coray T. Systemic and acquired immune responses in Alzheimer's disease. Int. Rev. Neurobiol. 2007, 82:205-233.
4. Chidrawar S., Khan N., Wei W., McLarnon A., Smith N., Nayak L., Moss P. Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clin. Exp. Immunol. 2009, 155:423-432.
5. Ciccocioppo F., Lanuti P., Marchisio M., Gambi F., Santavenere E., Pierdomenico L., Bascelli A., Velluto L., Gambi D., Miscia S. Expression and phosphorylation of protein kinase C isoforms in Abeta(1-42) activated T lymphocytes from Alzheimers disease. Int. J. Immunopathol. Pharmacol. 2008, 21:23-33.
6. Derhovanessian E., Maier A.B., Beck R., Jahn G., Hahnel K., Slagboom P.E., de Craen A.J., Westendorp R.G., Pawelec G. Hallmark features of immunosenescence are absent in familial longevity. J. Immunol. 2010, 185:4618-4624.
7. Fiala M., Lin J., Ringman J., Kermani-Arab V., Tsao G., Patel A., Lossinsky A.S., Graves M.C., Gustavson A., Sayre J., Sofroni E., Suarez T., Chiappelli F., Bernard G. Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. J. Alzheimers Dis. 2005, 7:221-232.
8. Goronzy J.J., Lee W.W., Weyand C.M. Aging and T-cell diversity. Exp. Gerontol. 2007, 42(5):400-406.
9. Griffin W.S., Mrak R.E. Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. J. Leukoc. Biol. 2002, 72(2):233-238.
10. Hamann D., Baars P.A., Rep M.H., Hooibrink B., Kerkhof-Garde S.R., Klein M.R., van Lier R.A. Phenotypic and functional separation of memory and effector human CD8+ T cells. J. Exp. Med. 1997, 186:1407-1418.
11. Ibegbu C.C., Xu Y.X., Harris W., Maggio D., Miller J.D., Kourtis A.P. Expression of killer cell lectin-like receptor G1 on antigen-specific human CD8+ T lymphocytes during active, latent, and resolved infection and its relation with CD57. J. Immunol. 2005, 174(10):6088-6094.
12. Koch S., Larbi A., Derhovanessian E., Özcelik D., Naumova E., Pawelec G. Multiparameter flow cytometric analysis of CD4 and CD8 T cellsubsets in young and old people. Immun. Ageing 2008, 5:6.
13. Larbi A., Pawelec G., Witkowski J.M., Schipper H.M., Derhovanessian E., Goldeck D., Fulop T. Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer's disease. J. Alzheimers Dis. 2009, 17(1):91-103.
14. Li M., Shang D.S., Zhao W.D., Tian L., Li B., Fang W.G., Zhu L., Man S.M., Chen Y.H. Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier. J. Immunol. 2009, 182(9):5778-5788.
15. Lombardi V.R., Garcia M., Rey L., Cacabelos R. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals. J. Neuroimmunol. 1999, 97:163-171.
16. Mayeux R., Honig L.S., Tang M.X., Manly J., Stern Y., Schupf N., Mehta P.D. PlasmaA[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk. Neurology 2003, 61:1185-1190.
17. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Service Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
18. Michie C.A., McLean A., Alcock C., Beverley P.C. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature 1992, 360:264-265.
19. Miscia S., Ciccocioppo F., Lanuti P., Velluto L., Bascelli A., Pierdomenico L., Genovesi D., Di Siena A., Santavenere E., Gambi F., Ausili-Cefaro G., Grimley P.M., Marchisio M., Gambi D. Abeta(1-42) stimulated T cells express P-PKC-delta and P-PKC-zeta in Alzheimer disease. Neurobiol. Aging 2009, 30:394-406.
20. Mocali A., Cedrola S., Della Malva N., Bontempelli M., Mitidieri V.A., Bavazzano A., Comolli R., Paoletti F., La Porta C.A. Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease. Exp. Gerontol. 2004, 39(10):1555-1561.
21. Monsonego A., Zota V., Karni A., Krieger J.I., Bar-Or A., Bitan G., Budson A.E., Sperling R., Selkoe D.J., Weiner H.L. Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease. J. Clin. Invest. 2003, 112:415-422.
22. Padovani A., Pastorino L., Borroni B., Colciaghi F., Rozzini L., Monastero R., Perez J., Pettenati C., Mussi M., Parrinello G., Cottini E., Lenzi G.L., Trabucchi M., Cattabeni F., Di Luca M. Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD. Neurology 2001, 57(12):2243-2248.
23. Pawelec G., Ouyang Q., Colonna-Romano G., Candore G., Lio D., Caruso C. Is human immunosenescence clinically relevant? Looking for 'immunological risk phenotypes'. Trends Immunol. 2002, 23:330-332.
24. Pellicanò M., Bulati M., Buffa S., Barbagallo M., Di Prima A., Misiano G., Picone P., Di Carlo M., Nuzzo D., Candore G., Vasto S., Lio D., Caruso C., Colonna-Romano G. Systemic immune responses in Alzheimer's disease: in vitro mononuclear cell activation and cytokine production. J. Alzheimers Dis. 2010, 21(1):181-192.
25. Reale M., Iarlori C., Feliciani C., Gambi D. Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease. J. Alzheimers Dis. 2008, 14(2):147-159.
26. Richartz-Salzburger E., Batra A., Stransky E., Laske C., Köhler N., Bartels M., Buchkremer G., Schott K. Altered lymphocyte distribution in Alzheimer's disease. J. Psychiatr. Res. 2007, 41(1-2):174-178.
27. Rojo L.E., Fernández J.A., Maccioni A.A., Jimenez J.M., Maccioni R.B. Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. Arch. Med. Res. 2008, 39(1):1-16.
28. Romero P., Zippelius A., Kurth I., Pittet M.J., Touvrey C., Iancu E.M., Corthesy P., Devevre E., Speiser D.E., Rufer N. Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J. Immunol. 2007, 178:4112-4119.
29. Sagare A.P., Deane R., Zetterberg H., Wallin A., Blennow K., Zlokovic B.V. Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-beta is an early biomarker for mild cognitive impairment preceding Alzheimer's disease. J. Alzheimers Dis. 2011, 24(1):25-34.
30. Sallusto F., Lenig D., Förster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401(6754):708-712.
31. Saresella M., Calabrese E., Marventano I., Piancone F., Gatti A., Calvo M.G., Nemni R., Clerici M. PD1 negative and PD1 positive CD4+T regulatory cells in mild cognitive impairment and Alzheimer's disease. J. Alzheimers Dis. 2010, 21:927-938.
32. Schupf N., Tang M.X., Fukuyama H., Manly J., Andrews H., Mehta P., Ravetch J., Mayeux R. Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(37):14052-14057.
33. Selkoe D.J. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J. Alzheimers Dis. 2001, 3(1):75-80.
34. Speciale L., Calabrese E., Saresella M., Tinelli C., Mariani C., Sanvito L., Longhi R., Ferrante P. Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients. Neurobiol. Aging 2007, 28:1163-1169.
35. Tarazona R., DelaRosa O., Alonso C., Ostos B., Espejo J., Peña J., Solana R. Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech. Ageing Dev. 2000, 121(1-3):77-88.
36. Togo T., Akiyama H., Iseki E., Kondo H., Ikeda K., Kato M., Oda T., Tsuchiya K., Kosaka K. Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases. J. Neuroimmunol. 2002, 124(1-2):83-92.
37. Town T., Tan J., Flavell R.A., Mullan M. T-cells in Alzheimer's disease. Neuromolecular Med. 2005, 7(3):255-264. Review.
38. Uberti D., Cenini G., Bonini S.A., Barcikowska M., Styczynska M., Szybinska A., Memo M. Increased CD44 gene expression in lymphocytes derived from Alzheimer disease patients. Neurodegener. Dis. 2010, 7(1-3):143-147.
39. Voehringer D., Blaser C., Brawand P., Raulet D.H., Hanke T., Pircher H. Viral infections induce abundant numbers of senescent CD8 T cells. J. Immunol. 2001, 167(9):4838-4843.
40. Voehringer D., Koschella M., Pircher H. Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1). Blood 2002, 100(10):3698-3702.
41. Weyand C.M., Goronzy J.J. Premature immunosenescence in rheumatoid arthritis. J. Rheumatol. 2002, 29(6):1141-1146.